Cargando…

Projected Real‐World Effectiveness of Using Aggressive Low‐Density Lipoprotein Cholesterol Targets Among Elderly Statin Users Following Acute Coronary Syndromes in Canada

BACKGROUND: The extent to which outcome benefits may be achieved through the implementation of aggressive low‐density lipoprotein (LDL) cholesterol targets in real world settings remains unknown, especially among elderly statin users following acute coronary syndromes. METHODS AND RESULTS: A populat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alter, David A., Tu, Jack V., Koh, Maria, Jackevicius, Cynthia A., Austin, Peter C., Rezai, Mohammad R., Bhatia, R. Sacha, Johnston, Sharon, Udell, Jacob A., Ko, Dennis T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015304/ https://www.ncbi.nlm.nih.gov/pubmed/29754125 http://dx.doi.org/10.1161/JAHA.117.007535

Ejemplares similares

Association of high-density lipoprotein cholesterol with non-fatal cardiac and non-cardiac events: a CANHEART substudy
por: Wijeysundera, Harindra C, et al.
Publicado: (2017)

Low Levels of Low-Density Lipoprotein Cholesterol and Mortality Outcomes in Non-Statin Users
por: Sung, Ki-Chul, et al.
Publicado: (2019)

Of statins and low-density lipoprotein cholesterol, “fats” and fiction
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2016)

Familial Resemblance in Low‐Density Lipoprotein Cholesterol Response to Statins in the Danish Population
por: Corn, Giulia, et al.
Publicado: (2022)

The Impact of Low-Density Lipoprotein Equation Changes on Cholesterol Treatment in Canada
por: Zhao, Pei Jun, et al.
Publicado: (2022)

Prevalence and Treatment of Familial Hypercholesterolemia and Severe Hypercholesterolemia in Older Adults in Ontario, Canada
por: Akioyamen, Leo E., et al.
Publicado: (2022)

Influence of serum cholesterol level and statin treatment on prostate cancer aggressiveness
por: Schnoeller, Thomas J., et al.
Publicado: (2017)

High-density lipoprotein cholesterol as a predictor of clinical outcomes in patients achieving low-density lipoprotein cholesterol targets with statins after percutaneous coronary intervention
por: Seo, Suk Min, et al.
Publicado: (2011)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Low-density lipoprotein cholesterol, statin therapy, and cerebral microbleeds: The CIRCLE study
por: Zhao, Yuqi, et al.
Publicado: (2023)

Statins and SARS‐CoV‐2 Infection: Results of a Population‐Based Prospective Cohort Study of 469 749 Adults From 2 Canadian Provinces
por: McAlister, Finlay A., et al.
Publicado: (2021)

Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency
por: Chinwong, Dujrudee, et al.
Publicado: (2015)

Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome
por: Im, Jihaeng, et al.
Publicado: (2021)

Statin Use and Stroke Rate in Older Adults With Atrial Fibrillation: A Population‐Based Cohort Study
por: Shweikialrefaee, Bisan, et al.
Publicado: (2023)

Role of Serum Cholesterol and Statin Use in the Risk of Prostate Cancer Detection and Tumor Aggressiveness
por: Morote, Juan, et al.
Publicado: (2014)

Cholesterol, Statins, and Alzheimer Disease
por: Koudinov, Alexei R, et al.
Publicado: (2005)

Optimal Target Level of Low-density Lipoprotein Cholesterol for Vascular Function in Statin Naïve Individuals
por: Matsui, Shogo, et al.
Publicado: (2017)

Low-Density Lipoprotein Cholesterol Level, Statin Use and Myocardial Infarction Risk in Young Adults
por: Jeong, Heekyoung, et al.
Publicado: (2022)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)

Association of Neighborhood-Level Material Deprivation With Atrial Fibrillation Care in a Single-Payer Health Care System: A Population-Based Cohort Study
por: Abdel-Qadir, Husam, et al.
Publicado: (2022)

Intensified low-density lipoprotein-cholesterol target of statin therapy and cancer risk: a meta-analysis
por: Sun, Haixia, et al.
Publicado: (2015)

Factors associated with door-in to door-out delays among ST-segment elevation myocardial infarction (STEMI) patients transferred for primary percutaneous coronary intervention: a population-based cohort study in Ontario, Canada
por: Shi, Oumin, et al.
Publicado: (2018)

Statins: Cholesterol guidelines and Indian perspective
por: Menon, Anil S., et al.
Publicado: (2015)

Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low‐Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients
por: Okerson, Ted, et al.
Publicado: (2017)

Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia
por: Henslee, Austin B., et al.
Publicado: (2018)

The Achievement of Non-high-density Lipoprotein Cholesterol Target in Patients with Very High Atherosclerotic Cardiovascular Disease Risk Stratified by Triglyceride Levels Despite Statin-controlled Low-density Lipoprotein Cholesterol
por: Al-Sabti, Hilal, et al.
Publicado: (2022)

Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease
por: Yen, Chieh‐Li, et al.
Publicado: (2022)

Comparison of the low-density lipoprotein cholesterol target value and the preventive effect of statins in elderly patients and younger patients
por: Endo, Akihiro, et al.
Publicado: (2017)

Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
por: Li, Yi-Heng, et al.
Publicado: (2020)

Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular disease
por: Weng, Stephen Franklin, et al.
Publicado: (2021)

Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery Disease
por: Ishii, Junnichi, et al.
Publicado: (2022)

Statin Treatment in Patients With Stroke With Low‐Density Lipoprotein Cholesterol Levels Below 70 mg/dL
por: Kim, Joon‐Tae, et al.
Publicado: (2023)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
por: Willeit, Peter, et al.
Publicado: (2020)

Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada
por: Udell, Jacob A., et al.
Publicado: (2022)

Does Lowering Low‐Density Lipoprotein Cholesterol With Statin Restore Low Risk in Middle‐Aged Adults? Analysis of the Observational MESA Study
por: Liu, Kiang, et al.
Publicado: (2021)

Differential Benefit of Statin in Secondary Prevention of Acute Myocardial Infarction according to the Level of Triglyceride and High Density Lipoprotein Cholesterol
por: Kim, Kyung Hwan, et al.
Publicado: (2016)

Validity of a Novel Method for Estimating Low-Density Lipoprotein Cholesterol Levels in Cardiovascular Disease Patients Treated with Statins
por: Sonoda, Takeshi, et al.
Publicado: (2018)

Effect of Ezetimibe Added to High-Intensity Statin Therapy on Low-Density Lipoprotein Cholesterol Levels: A Meta-Analysis
por: Lee, Jayden, et al.
Publicado: (2021)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
por: Cheng, Yinchu, et al.
Publicado: (2022)

Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance
por: Ward, Natalie C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7q1pmeo4hgj3h1lkbgp31evid0